Will NSABP FB-10 Become a Phase III Trial?

aacr2017 has 92 videos Subscribe Here

Description: Jame Abraham, MD of Cleveland Clinic discusses his hopes for NSABP-FB10 becoming a Phase II and Phase III trial for patients with breast cancer. He also discusses how to manage the diarrhea and nausea in patients who underwent this study. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Shared By : aacr2017
Posted on : 04/18/17
Added : 7 months ago
Category : Breast Cancer


Nothing found.

More From aacr2017

Nothing found.